Mettler Toledo International Inc's market capitalization of $23,218,327,566 is ahead of 91.75% of US-listed equities.
Mettler Toledo International Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 94.19% of US listed stocks.
With a one year PEG ratio of 5,037.23, Mettler Toledo International Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 99.44% of US stocks.
Stocks that are quantitatively similar to MTD, based on their financial statements, market capitalization, and price volatility, are TRU, CLX, CSGP, IDXX, and MED.
Mettler-Toledo International, Inc. (MTD) Company Bio
Mettler-Toledo International is a provider of weighing instruments for use in laboratory, industrial and food retailing applications. The Company is also a provider in analytical instruments for use in life science, reaction engineering and real-time analytic systems used in drug and chemical compound development and process analytics instruments used for in-line measurement in production processes. As well, the company supplies inspection systems used in production and packaging for food, pharmaceutical and other industries. The company was founded in 1991 and is based in Columbus, Ohio.
MTD Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Mettler Toledo International Inc. To summarize, we found that Mettler Toledo International Inc ranked in the 19th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Mettler Toledo International Inc ended up being:
Interest coverage, a measure of earnings relative to interest payments, is 18.18; that's higher than 82.45% of US stocks in the Healthcare sector that have positive free cash flow.
The business' balance sheet suggests that 5% of the company's capital is sourced from debt; this is greater than merely 14.35% of the free cash flow producing stocks we're observing.
MTD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 44.15% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
CNMD, MMSI, NRC, AZN, and BIO can be thought of as valuation peers to MTD, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
COLUMBUS, Ohio and BOSTON, Aug. 13, 2020 /PRNewswire/ -- METTLER TOLEDO International Inc. (NYSE: MTD) and TetraScience, Inc. announce a new collaboration to knock down life sciences R&D data silos by providing complete and unified R&D data in the cloud. The integration will join METTLER…
Mettler Toledo (MTD) reports Q2 revenue $690.67M (-5.6% Y/Y), beating consensus.By region, local currency sales decreased 2% in the Americas, 5% in Europe and 3% in Asia/Rest of World.Adjusted operating profit amounted to $317.9M (-2% Y/Y)Q3 outlook: Sales to decline 1%-3%, Adjusted EPS is forecasted to be in the range of $5.80-6.00.2020 full-year outlook: Sales...